Jerel Davis 4
4 · Turnstone Biologics Corp. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Jerel Davis
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-03+12,770→ 12,770 totalExercise: $2.69Exp: 2034-06-02→ Common Stock (12,770 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of June 3, 2025 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.